Traditional pharmacovigilance relies on spontaneous reports to detect adverse drug reactions, but the increasing use of social media presents a new opportunity. Web-based data offers a substantial volume and real-time availability, which can enhance the early detection of signals of disproportionate reporting (SDRs). Leveraging social media data could provide timely insights into potential safety concerns and improve pharmacovigilance practices.